Journal
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
Volume 40, Issue 1, Pages -Publisher
BMC
DOI: 10.1186/s13046-021-01845-6
Keywords
Gut microbiota; Immunity; Metabolism; Gut-brain; liver; lung axis
Categories
Funding
- National Science Foundation of China [81272297]
- Hunan Province Key Research and Development Project [2020SK2053]
Ask authors/readers for more resources
Recent scientific advances have shown the complex relationship between the gut microbiome and cancer. Changes in gut microbiota composition can lead to immune dysregulation, promoting chronic inflammation and tumor development. Gut microorganisms and their metabolites can affect inflammation and tumorigenesis in specific organs through various axes of interaction.
Recent scientific advances have greatly enhanced our understanding of the complex link between the gut microbiome and cancer. Gut dysbiosis is an imbalance between commensal and pathogenic bacteria and the production of microbial antigens and metabolites. The immune system and the gut microbiome interact to maintain homeostasis of the gut, and alterations in the microbiome composition lead to immune dysregulation, promoting chronic inflammation and development of tumors. Gut microorganisms and their toxic metabolites may migrate to other parts of the body via the circulatory system, causing an imbalance in the physiological status of the host and secretion of various neuroactive molecules through the gut-brain axis, gut-hepatic axis, and gut-lung axis to affect inflammation and tumorigenesis in specific organs. Thus, gut microbiota can be used as a tumor marker and may provide new insights into the pathogenesis of malignant tumors.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available